ReviewJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Stereotactic body radiotherapy in lung cancer: an update.
Review in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.Cancer treatment and research · 2023Pooled it
- Review on endobronchial therapies-current status and future.Annals of translational medicine · 2024Review
- A high-resolution large-area detector for quality assurance in radiotherapy.Scientific reports · 2024Article
- Review
- Real-World Evidence of Health Outcomes Related to Lung Stereotactic Body Radiation Therapy in Brazil.JCO global oncology · 2022Article
- CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT).Cancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Applying PET-CT for predicting the efficacy of SBRT to inoperable early-stage lung adenocarcinoma: A Brazilian case-series.Lancet regional health. Americas · 2022Article
- Access of Patients With Lung Cancer to High Technology Radiation Therapy in Brazil.JCO global oncology · 2021Article
- Contribution of Imaging to Organs at Risk Dose during Lung Stereotactic Body Radiation Therapy.Journal of biomedical physics & engineering · 2021Article
- Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours.Frontiers in oncology · 2021Article
- A Minimal PKPD Interaction Model for Evaluating Synergy Effects of Combined NSCLC Therapies.Journal of clinical medicine · 2020Article
- Stereotactic Body Radiation Therapy for Biopsy-Proven Primary Non-Small-Cell Lung Cancer: Experience of Patients With Inoperable Cancer at a Single Brazilian Institution.Journal of global oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For early-stage lung cancer, the treatment of choice is surgery. In patients who are not surgical candidates or are unwilling to undergo surgery, radiotherapy is the principal treatment option. Here, we review stereotactic body radiotherapy, a technique that has produced quite promising results in such patients and should be the treatment of choice, if available. We also present the major indications, technical aspects, results, and special situations related to the technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.